N-(2-CYANETHYLENE)UREA, AN ASPARAGINE ANALOGOUS CYTOSTATIC COMPOUND.BICKER U.1975; EXPER. PATHOL.; DTSCH.; DA. 1975; VOL. 10; NO 1-2; PP. 106-108; BIBL. 10REF.Article

APPLICATION OF BETA -D-GLUCURONIDES AND GLUCOSE TOGETHER SUGGESTS A NEW DIRECTION FOR CANCER CHEMOTHERAPY = L'APPLICATION SIMULTANEE DE BETA -D-GLUCURONIDES ET DE GLUCOSE SUGGERE UNE NOUVELLE ORIENTATION POUR LA CHIMIOTHERAPEUTIQUE DU CANCERBICKER U.1974; NATURE; G.B.; DA. 1974; VOL. 252; NO 5485; PP. 726-727; BIBL. 11REF.Article

THERAPEUTIC EFFECTS OF BM 12,531 (PROP. INN AZIMEXON)BICKER U.1980; RECENT RESULTS CANCER RES.; ISSN 0080-0015; USA; DA. 1980; NO 75; PP. 147-152; BIBL. 6 REF.Article

BIOCHEMISCHE UND PHARMAKOLOGISCHE EIGENSCHAFTEN NEUER 2-SUBSTITUIERTER AZIRIDINE. BEITRAGE ZUR EXPERIMENTELLEN KREBSFORSCHUNG. = PROPRIETES BIOCHIMIQUES ET PHARMACOLOGIQUES DE NOUVELLES 2-AZIRIDINES SUBSTITUEES. CONTRIBUTIONS A LA RECHERCHE EXPERIMENTALE SUR LE CANCERBICKER U.1978; FORTSCHR. D. MED.; DTSCH.; DA. 1978; VOL. 96; NO 12; PP. 661-664; ABS. ANGL.; BIBL. 10 REF.Article

ENDOGENE BILDUNG KANZEROGENER AZIRIDINE = FORMATION ENDOGENE D'AZIRIDINES CANCEROGENES (ETHYLENIMINES)BICKER U.1974; ARCH. GESCHW.-FORSCH.; DTSCH.; DA. 1974; VOL. 44; NO 4; PP. 312-318; ABS. ANGL.; BIBL. 24REF.Article

Some new aspects in autoimmunityBICKER, U.Journal of immunopharmacology. 1986, Vol 8, Num 4, pp 543-559, issn 0163-0571Article

CANCEROSTATIC ACTION OF THE IMMUNE-STIMULATING COMPOUND 4-IMINO-1,3-DIAZABICYCLO-(3, 1, 0)-HEXAN-2-ONE, BM 06002, (PROPOSED INN IMEXON) ON VARIOUS TRANSPLANTATION TUMOURS.BICKER U; HEBOLD G.1977; I.R.C.S. J. MED. SCI.; G.B.; DA. 1977; VOL. 5; NO 9; PP. 428; BIBL. 2 REF.Article

CARCINOSTATIC ACTION OF 2-CYANAZIRIDINES AGAINST A SARCOMA IN RATS.BICKER U; FUHSE P.1975; EXPER. PATHOL.; DTSCH.; DA. 1975; VOL. 10; NO 5-6; PP. 279-284; BIBL. 13 REF.Article

ENZYMATIC AZIRIDINE SYNTHESIS FROM BETA AMINOALCOHOLS - A NEW EXAMPLE OF ENDOGENOUS CARCINOGEN FORMATION = SYNTHESE ENZYMATIQUE D'AZIRIDINE A PARTIR D'ALCOOLS BETA -AMINES - NOUVEL EXEMPLE DE FORMATION ENDOGENE DE CANCEROGENESBICKER U; FISCHER W.1974; NATURE; G.B.; DA. 1974; VOL. 249; NO 5455; PP. 344-345; BIBL. 7REF.Article

EXPERIMENTELLE UNTERSUCHUNGEN ZUR VERSTAERKUNG DER ZELLVERMITTELTEN IMMUNREAKTIVITAET DURCH 4-IMINO-1,3-DIAZABICYCLO-(3.1.0) HEXAN 2-ON (BM 06.002, PROP. INN IMEXON). = ETUDES EXPERIMENTALES SUR LA STIMULATION DE L'IMMUNITE CELLULAIRE PAR IMINO-4 DIAZA-1,3 BICYCLO(3.1.0) HEXANNE-2 (BM 06.002. PROP. INN IMEXON)BICKER U; HEBOLD G.1977; OESTERR. Z. ONKOL.; OESTERR.; DA. 1977; VOL. 4; NO 2-3; PP. 55-56; ABS. ANGL.; BIBL. 12 REF.Article

WEITERE ERKENNTNISSE UEBER DIE ENDOGENE BILDUNG VON KANZEROGENEN N-NITROSOVERBINDUNGEN. II. = NOUVELLES RECHERCHES SUR LA FORMATION ENDOGENE DES DERIVES N-NITRES CANCERIGENES. II.BICKER U; OSSKE G.1974; ARCH. GESCHW.-FORSCH.; DTSCH.; DA. 1974; VOL. 43; NO 3; PP. 244-249; ABS. ANGL.; BIBL. 1P.1/2Article

UEBER DIE WACHSTUMSHEMMENDE WIRKUNG VON TRENIMON AUF EIN N-METHYLNITROSOHARNSTOFF INDUZIERTES SARKOM BEI IN-VIVO-TESTUNG = TEST IN VIVO DE L'ACTIVITE CYTOSTATIQUE DU TRENIMON SUR UN SARCOME INDUIT PAR DE L'N-METHYLNITROSUREE (NMU)FUHSE P; BICKER U; TUST R et al.1974; ARCH. GESCHW.-FORSCH.; DTSCH.; DA. 1974; VOL. 44; NO 2; PP. 130-133; ABS. ANGL.; BIBL. 15REF.Article

ENHANCED PHA STIMULATION OF CANCER PATIENTS' LYMPHOCYTES BY ADDITION OF BM 12531 (AZIMEXON) IN VITROCOLOT M; MICKSCHE M; BICKER U et al.1979; CANCER IMMUNOL. IMMUNOTHERAPY; DEU; DA. 1979; VOL. 6; NO 3; PP. 175-178; BIBL. 29 REF.Article

INVESTIGATION IN MICE ON THE POTENTIATION OF RESISTANCE TO INFECTIONS BY A NEW IMMUNOSTIMULANT COMPOUNDBICKER U; ZIEGLER AE; HEBOLD G et al.1979; J. INFECT. DIS.; ISSN 0022-1899; USA; DA. 1979; VOL. 139; NO 4; PP. 389-395; BIBL. 16 REF.Article

EXPERIMENTAL INVESTIGATIONS ON INCREASED RESISTANCE TO INFECTIONS WITH CANDIDA ALBICANS AND STAPHYLOCOCCUS AUREUS SMITH BY 4-IMINO-1,4 DIAZOBICYCLO (3.1.0.) HEXANE 2-ON BM06.002. (PROP. INN IMEXON) IN MICEZIEGLER AE; BICKER U; HEBOLD G et al.1977; EXPER. PATHOL.; DDR; DA. 1977; VOL. 14; NO 6; PP. 321-327; BIBL. 13 REF.Article

REDUCTION OF ACUTE TOXICITY OF CYCLOPHOSPHAMIDE AND X-RAYS BY THE NEW IMMUNOMODULATING COMPOUND BM 12531BICKER U; FRIEDBERG KD; HEBOLD G et al.1979; EXPERIENTIA; CHE; DA. 1979; VOL. 35; NO 10; PP. 1361-1363; BIBL. 16 REF.Article

TUMORENTSTEHUNG DURCH ENDOGEN GEBILDETE KANZEROGENE NACH GABE VON N-PROPYL-, ISO-PROPYL-BZW. N-BUTYLHARNSTOFF UND NITRIT BEI RATTEN = INDUCTION DE TUMEURS CHEZ LE RAT APRES ADMINISTRATION DE N-PROPYL-ISO-PROPYL OU N-BUTYLUREE ET DE NITRITE, EVOLUANT EN CANCERIGENES ENDOGENESSCHNEIDER J; BICKER U; WARZOK R et al.1974; ARCH. GESCHW.-FORSCH.; DTSCH.; DA. 1974; VOL. 44; NO 2; PP. 126-129; ABS. ANGL.; BIBL. 13REF.Article

INFLUENCE OF BM 12-531 (PROP. INN AZIMEXON) ON THE LYMPHOCYTE TRANSFORMATION AND THE PERCENTAGE OF ACTIVE T LYMPHOCYTES IN VIVO AND IN VITRO IN MANBOERNER D; BICKER U; ZIEGLER AE et al.1979; CANCER IMMUNOL. IMMUNOTHERAPY; DEU; DA. 1979; VOL. 6; NO 4; PP. 237-242; BIBL. 10 REF.Article

IMMUNESTIMULATION IN CANCER PATIENTS BY A NEW SYNTHETIC COMPOUND: BM 06002MICKSCHE M; KOKOSCHKA EM; KOKRON O et al.1977; OESTERR. Z. ONKOL.; OESTERR.; DA. 1977; VOL. 4; NO 1; PP. 29-32; ABS. ALLEM.; BIBL. 24 REF.Article

EPAMINIERUNGEN. II. HERSTELLUNG VON AZIRIDINEN AUS OLEFINEN UND N-HALOGENAMINEN = EPIAMINATIONS. II. PREPARATION D'AZIRIDINES A PARTIR D'OLEFINES ET DE N-HALOGENOAMINESSCHMITZ E; BICKER U; SCHRAMM S et al.1978; J. PRAKT. CHEM.; DDR; DA. 1978; VOL. 320; NO 3; PP. 413-421; ABS. ENG; BIBL. 19 REF.Article

Ciamexone: a new highly selective immunosuppressive compoundBICKER, U; PAHLKE, W.Journal of immunopharmacology. 1985, Vol 7, Num 1, pp 127-139, issn 0163-0571Article

NEBENREAKTIONEN DER CHLORAMINHERSTELLUNG = REACTIONS SECONDAIRES LORS DE LA PREPARATION DE LA CHLORAMINESCHMITZ E; SCHRAMM S; FLAMME W et al.1973; Z. ANORG. ALLG. CHEM.; DTSCH.; DA. 1973; VOL. 396; NO 2; PP. 178-184; ABS. ANGL.; BIBL. 17 REF.Serial Issue

CLINICAL STUDIES OF BM 06002. A NEW IMMUNOSTIMULANT DRUG.MICKSCHE M; KOKOSCHKA EM; SAGASTER P et al.1977; I.R.C.S. J. MED. SCI.; G.B.; DA. 1977; VOL. 5; NO 4; PP. 192; BIBL. 3 REF.Article

Optimizing the lymphocyte transformation test in whole blood. I: Optimum conditions for thymidine incorporationBICKER, U; SCHAUMANN, W; HAAS, V et al.Journal of immunopharmacology. 1983, Vol 5, Num 1-2, pp 1-12, issn 0163-0571Article

Investigations on the age-dependence of T-lymphocyte subpopulations and lymphocyte reactivityREITER, J. J; EHRLICH, G; BICKER, U et al.Journal of immunopharmacology. 1984, Vol 6, Num 4, pp 359-377, issn 0163-0571Article